...
首页> 外文期刊>Vascular Health and Risk Management >Anxiety and depression in patients with pulmonary hypertension: impact and management challenges
【24h】

Anxiety and depression in patients with pulmonary hypertension: impact and management challenges

机译:肺动脉高压患者的焦虑和抑郁:影响和管理挑战

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Anxiety and depression are frequent disorders in patients with pulmonary arterial hypertension (PAH), but despite this only less than one-fourth of them is treated. Our aim was to review the studies regarding the prevalence and the impact of anxiety and depression and to propose management challenges. Methods: A literature review regarding 1) anxiety and depression studies in PAH patients and caregivers, 2) psychological interventions, 3) slow breathing approach, and 4) pharmacological approach was performed, based on evidence of effectiveness through a search of the most well-known databases (Cochrane Library, Medline, PsychINFO [2004–2018]). Results: The prevalence of mental disorders in PAH patients lies between 7.5% and 53% for depression and 19% and 51% for anxiety and panic disorders. The latest guidelines of the European Society of Cardiology recommend a psychological support with a class of recommendation I and a level of evidence c. The analysis of psychological intervention shows that at present there is no evidence of specific psychological interventions in these patients. However, treatment approaches based on other chronic illnesses are suggested, especially based on relaxation training, slow breathing, and cognitive behavioral therapy. Finally, data concerning the use of antidepressant drugs are conflicting. Conclusion: Firstly, our data demonstrate a common underestimation of mental disorders by health professionals and secondly, the need of implementing appropriate methods of screening for mental disorders in PAH patients. However, the paucity of large observational studies in this area requires the attention of researchers. The evidence about optimal approaches for managing anxiety and depression in PAH also remains unclear and largely speculative. The challenge is the introduction of routine psychological intervention, as suggested by the European Society of Cardiology and already applied in other chronic disease.
机译:背景:焦虑和抑郁是肺动脉高压(PAH)患者的常见疾病,尽管如此,只有不到四分之一的患者得到了治疗。我们的目的是回顾有关焦虑症和抑郁症的患病率及其影响的研究,并提出管理方面的挑战。方法:文献综述涉及1)在PAH患者和护理人员中进行的焦虑和抑郁研究,2)心理干预,3)呼吸缓慢方法和4)药理学方法,其依据是通过寻找最有效的方法来证明其有效性。已知数据库(Cochrane图书馆,Medline,PsychINFO [2004–2018])。结果:PAH患者的精神疾病患病率在抑郁症的7.5%至53%之间,而焦虑和惊恐疾病的患病率在19%至51%之间。欧洲心脏病学会的最新指南推荐了心理支持,其中包括建议I和证据等级c。对心理干预的分析表明,目前尚无针对这些患者的具体心理干预的证据。但是,建议了基于其他慢性疾病的治疗方法,尤其是基于放松训练,缓慢呼吸和认知行为疗法的治疗方法。最后,有关使用抗抑郁药的数据存在矛盾。结论:首先,我们的数据表明卫生专业人员普遍低估了精神障碍,其次,需要对PAH患者实施适当的筛查精神障碍的方法。但是,这一领域的大型观察研究很少,需要研究人员的注意。关于控制PAH焦虑和抑郁的最佳方法的证据也仍然不清楚,并且在很大程度上是推测性的。挑战是引入常规的心理干预措施,正如欧洲心脏病学会所建议的那样,并且已经应用​​于其他慢性疾病中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号